Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis

Abstract

Vortioxetine was associated with rates of TESD that were not significantly different from placebo in short-term clinical trials.